New York - Johnson & Johnson might sell its Ortho Clinical Diagnostics business if it can find the right price, chief executive officer Alex Gorsky said Tuesday morning.
The division has its headquarters in Raritan, N.J., and its research and development center in Rochester, N.Y.
Gorsky said J&J is "initiating the first steps," in the divestiture process of that division.
"When you look at diagnostics, we have good technology and a lot of good businesses, but they are not No. 1 or 2 in the market," Gorsky said.